Skip to main content

Advertisement

Table 1 clinical and pathological information of RCC patients

From: Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing

Sample ID Gender Age at Diagnosis Surgical Approach Histological Subtype Laterality Tumor Grade TNM Stage Tumor Stage
1 M 44 LSRN ccRCC Left G3 T3aN0M0 III
3 M 33 LSPN ccRCC Left G1 T1aN0M0 I
4 M 60 LSRN ccRCC Left G2 T1aN0M0 I
5 F 52 LSPN ccRCC Left G1 T1aN0M0 I
6 M 59 LSPN ccRCC Left G1 T1aN0M0 I
7 F 59 LSRN ChRCC Right NA T1bN0M0 I
8 F 70 LSPN ccRCC Right G1 T1aN0M0 I
9 F 58 LSRN ccRCC Right G2 T3aN0M0 III
10 M 49 LSRN ccRCC Right G2 T2aN0M0 II
11 M 70 LSRN ccRCC Right G1 T1bN0M0 I
12 M 76 LSRN ccRCC Right G3 T3bN0M0 III
13 M 46 LSPN ccRCC Left G3 T1aN0M0 I
14 M 63 LSRN ccRCC Right G2 T1bN0M0 I
15 M 52 LSRN ccRCC Left G1 T1bN0M0 I
25 F 43 ORN ChRCC Left NA T2bN0M0 II
36 M 38 LSRN ccRCC Left G3 T1aN0M0 I
38 M 60 LSRN ccRCC Left G1 T1bN0M0 I
39 F 24 LSRN ChRCC Right NA T1bN0M0 I
78 M 54 LSRN ChRCC Left NA T3aN0M0 III
82 F 76 LSPN PRCC (II) Right G3 T1aN0M0 I
98 F 63 LSPN ChRCC Left NA T1aN0M0 I
114 M 65 LSRN ChRCC Right NA T1bN0M0 I
129 M 52 LSRN PRCC (II) Right G2 T3aN0M0 III
130 F 78 LSRN PRCC (II) Right G2 T1bN0M0 I
131 M 72 LSPN PRCC (II) Right G2 T1aN0M0 I
137 M 38 LSPN PRCC (I) Right G2 T1aN0M0 I
  1. M, male; F, female; LSRN, laparoscopic radical nephrectomy; LSPN, laparoscopic partial nephrectomy; ORN, open radical nephrectomy; NA, not available